Mepolizumab in eosinophilic disorders

被引:1
|
作者
Abonia, J. Pablo [2 ]
Putnam, Philip E. [1 ]
机构
[1] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr,Coll Med, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Div Allergy & Immunol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
关键词
anti-IL-5; eosinophilic gastrointestinal disorders; eosinophils; human; IL-5; mepolizumab; RECOMBINANT HUMAN INTERLEUKIN-5; HUMANIZED MONOCLONAL-ANTIBODY; CHURG-STRAUSS-SYNDROME; IDIOPATHIC HYPEREOSINOPHILIC SYNDROME; INFLAMMATORY-BOWEL-DISEASE; AIRWAY HYPERRESPONSIVENESS; CLINICAL CHARACTERISTICS; DIFFERENTIATION FACTOR; IMATINIB MESYLATE; ESOPHAGITIS;
D O I
10.1586/ECI.11.27
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mepolizumab (Bosatria (R), GlaxoSmithKline) is a biologic agent developed to treat asthma. It represents a humanized monoclonal antibody of IgG1 kappa type, which targets human IL-5 and thus prevents its interaction with the alpha-chain of the IL-5 receptor. To date, it has not been approved for use in any eosinophil-related disorder; however, several studies have suggested some therapeutic benefit across a spectrum of eosinophil-related disorders. This article evaluates the currently available preclinical and clinical studies, and the impact of mepolizumab against a variety of eosinophilic disorders.
引用
收藏
页码:411 / 417
页数:7
相关论文
共 50 条
  • [31] Steroid-sparing effect of mepolizumab in children with severe eosinophilic nonallergic asthma
    Tosca, Maria Angela
    Girosi, Donata
    Sacco, Oliviero
    Bernardini, Roberto
    Ciprandi, Giorgio
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2021, 49 (05) : 113 - 116
  • [32] Isolated CNS involvement in eosinophilic granulomatosis with polyangiitis treated with mepolizumab: A case report
    Son, Hyoshin
    Lee, Woo-Jin
    Moon, Jangsup
    Yoon, Sungjoon
    Jung, Keun-Hwa
    Park, Kyung-Il
    Lee, Sang Kun
    Chu, Kon
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 355
  • [33] Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
    Varricchi, Gilda
    Bagnasco, Diego
    Ferrando, Matteo
    Puggioni, Francesca
    Passalacqua, Giovanni
    Canonica, Giorgio W.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (01) : 40 - 45
  • [34] Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab
    Tsurikisawa, Naomi
    Oshikata, Chiyako
    Watanabe, Maiko
    Fukuda, Nobuhiko
    Yamaguchi, Takanori
    Kiyohara, Hikari
    Kaneko, Takeshi
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2021, 182 (08) : 744 - 756
  • [35] Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty
    Otoshi, Ryota
    Baba, Tomohisa
    Komatsu, Shigeru
    Asaoka, Masato
    Hagiwara, Eri
    Ogura, Takashi
    RESPIROLOGY CASE REPORTS, 2020, 8 (02):
  • [36] Mepolizumab and pregnancy: A case of severe eosinophilic asthma in a patient who conceived during mepolizumab treatment
    Aksu, Kurtulus
    Yagdiran, Melis
    Tuglu, Hatice Celik
    Telli, Onur
    Akkale, Ozgur
    Celik, Fatma Dindar
    EURASIAN JOURNAL OF PULMONOLOGY, 2025, 27 (01) : 62 - 64
  • [37] Predictors of histologic response to mepolizumab in pediatric eosinophilic esophagitis
    Wong, Emily C. L.
    Gleave, Alexandra L.
    Marshall, John K.
    Narula, Neeraj
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (10) : 1131 - 1136
  • [38] Mepolizumab for the Treatment of Eosinophilic Granulomatosis With Polyangiitis: Our Experience
    Diaz-Campos, R. M.
    Prudencio-Ribera, V. C.
    Garcia-Moguel, I
    Fernandez-Rodriguez, C.
    Corral-Blanco, M.
    Jarrin-Estupinan, M. E.
    Melero-Moreno, C.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (05) : 384 - 385
  • [39] Biological Modulators in Eosinophilic Diseases
    Sriaroon, Panida
    Ballow, Mark
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2016, 50 (02) : 252 - 272
  • [40] Malnutrition in Eosinophilic Gastrointestinal Disorders
    Votto, Martina
    De Filippo, Maria
    Olivero, Francesca
    Raffaele, Alessandro
    Cereda, Emanuele
    De Amici, Mara
    Testa, Giorgia
    Marseglia, Gian Luigi
    Licari, Amelia
    NUTRIENTS, 2021, 13 (01) : 1 - 12